The Resurgence and Clinical Development of Influenza A in Pediatric Populations in China: Changes in Epidemiology and Serological Patterns from Pre-Pandemic to Post-Pandemic Periods (2019–2023) - Takeaways - MDSpire

The Resurgence and Clinical Development of Influenza A in Pediatric Populations in China: Changes in Epidemiology and Serological Patterns from Pre-Pandemic to Post-Pandemic Periods (2019–2023)

  • By

  • Guiling Xu

  • Yu Chen

  • Yu Zhu

  • Qing Fang

  • Xiaotong Xue

  • Kejun Hu

  • Sha Zhou

  • Li Hong

  • Ying Xiang

  • January 17, 2026

  • 0 min

Share

  • 1

    Influenza A is a significant cause of acute respiratory infections in children, with varying severity and risk factors for complications.

  • 2

    COVID-19 interventions disrupted influenza A's seasonal epidemiology, leading to increased immune debt in pediatric populations.

  • 3

    Shanghai's pediatric influenza vaccination rates increased post-COVID-19, with the highest rates seen in children aged 0-4 years.

  • 4

    From mid-February to late April 2023, China experienced an influenza A epidemic, primarily of the H1N1 subtype, surpassing pre-pandemic levels.

  • 5

    A large-scale study at Shanghai Children’s Medical Center aims to analyze influenza A's epidemiology and guide future prevention strategies.

Original Source(s)

Related Content